Press Releases - 2021-02-02

Date	Title	Company
02-Feb-2021	Janssen Announces CAR-T Therapy Ciltacabtagene Autoleucel (Cilta-cel) Accepted for Accelerated Assessment in Europe for the Treatment of Patients with Heavily Pretreated Multiple Myeloma	Janssen
02-Feb-2021	RauCon Guarantees Business Development Event Planning Dependability	RauCon
02-Feb-2021	Sputnik V vaccine authorized in Armenia	The Russian Direct Investment Fund
02-Feb-2021	Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications	Recipharm and Medspray
02-Feb-2021	Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA	Prothena
02-Feb-2021	Tiziana Reports Positive Data from the Clinical Study of Nasal Administration with Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, in COVID-19 Patients in Brazil	Tiziana
02-Feb-2021	Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	Verona Pharma
02-Feb-2021	Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line Development Projects	Harbour BioMed and ProBioGen
02-Feb-2021	ONTOZRYTM (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults*	Arvelle Therapeutics
02-Feb-2021	A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet	Russian Direct Investment Fund
02-Feb-2021	Bristol Myers Squibb Announces Positive Topline Results from Second Pivotal Phase 3 Psoriasis Study Showing Superiority of Deucravacitinib Compared to Placebo and Otezla® (apremilast)	Bristol Myers Squibb
02-Feb-2021	PUSH DOCTOR PARTNERS WITH WELL PHARMACY TO LAUNCH THE COUNTRY’S FIRST ‘PHARMACY-FIRST’ DIGITAL HEALTH SERVICE	PUSH DOCTOR
02-Feb-2021	Novartis receives positive CHMP opinion for Kesimpta® (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis with active disease	Novartis
02-Feb-2021	Surface Plasmon Resonance Market Outlook 2019-2027\| Global Growth Analysis and Forecast Report with Key Players – HORIBA, Ltd, General Electric Co., Biosensing Instrument Inc., Nicoya Lifesciences Inc.	MARKITWIRED
02-Feb-2021	NEW APP SET TO TRANSFORM CARE FOR PATIENTS WITH DIABETES CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST & SENSYNE HEALTH COLLABORATE TO DEVELOP REMOTE SUPPORT AND MANAGEMENT APP FOR PATIENTS WITH DIABETES	Chelsea and Westminster Hospital NHS Foundation Trust
02-Feb-2021	Cardiac Assist Devices Market Swot Analysis by Key Players: Terumo Corporation, Medtronic PLC, Abbott Laboratories, Abiomed Inc	MARKITWIRED
02-Feb-2021	Bayer receives approval in the UK for Xarelto® (rivaroxaban) to treat children with venous thromboembolism (VTE) and to prevent VTE recurrence	Bayer
02-Feb-2021	Prefilled Syringes Drug Molecules Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2027	MARKITWIRED
02-Feb-2021	Global Pressure Bandages Market is projected to grow at a CAGR of 3.3% during the forecast period of 2017–2027.	MARKITWIRED
02-Feb-2021	Aidian Appointed Sole Distributor of PixCell Medical’s Point-of-Care Hematological Analyzer HemoScreen™ in the Nordics	PixCell Medical